Index infection |
Infection present at the time of organ dysfunction or up to 3 days before onset of organ dysfunction |
Hospital mortality |
Death in hospital before discharge |
ICU mortality |
Death in ICU |
Independent functional status at hospital discharge |
“Independent” vs. “other” functional status. “Independent” is defined when the patient is discharged home and independent in activities of daily living. “Other” functional status includes categories of partially dependent, fully dependent, or dead. |
Hospital length of stay |
Number of consecutive days in current acute care hospital |
ICU length of stay |
Number of consecutive days in ICU. Only the duration of the first ICU stay during hospitalization is counted. |
Age |
Age of the patient in years |
Gender |
Male or female |
SAPS II* score |
Calculated from the necessary variables provided in the CPI dataset according to the methods of LeGall, et al 1
|
SAPS II predicted mortality |
Calculated from the necessary variables provided in the CPI dataset according to the methods of LeGall, et al 1
|
APACHE II score |
Calculated from the variables provided in the CPI dataset according to the methods of Knaus, et al 2
|
Origin prior to hospital admission |
Admission from the community vs. a health-care associated facility, the latter including another location within the hospital or transfer from another hospital |
Previous ICU admission |
Previous ICU admission within the same hospitalization |
Acute renal failure |
Creatinine > 1.5 mg/dL evident < 48 hours before ICU admission and associated with oliguria |
CPR within 24 hours of ICU admission |
Self-expanatory |
Functional status on hospital admission |
“Independent” vs. “other” functional status. The “other” category includes partially dependent and fully dependent. |
Code status on ICU admission |
Full vs. “limited.” The “limited” category included no CPR, limited interventions/ withholding therapy, or withdrawing therapy/ comfort care code status. |
Medicine service vs. surgery |
Surgical category includes elective and emergent surgical admissions |
Index infection |
Current infection present at or up to 3 days prior to the time when acute organ dysfunction was detected. At least one of the following conditions must be met: antibiotics started for presumed infection; antibiotics administered for a known active infection (not for antibiotic prophylaxis); purulent drainage from wound or catheter site; radiological evidence of infiltrates and sputum production; white blood cells present in a normally sterile body fluid. |
Intra-abdominal infection |
Infection in the abdominal compartment and pelvis. Includes peritoneal fluid, abscess drainage, and fluid from surgical drain. |
Bloodstream infection |
Bloodstream infection not due to vascular access site |
Chest infection |
Infection of lungs, pleura, pleural fluid, or drainage around chest tube site |
CNS infection |
Infection of brain, meninges, CSF, spine, or drainage from or around invasive CNS device |
Sinus infection |
Infection of fluid in cranial or facial sinus cavity |
Surgical infection |
Infection of any surgical wound site regardless of location |
Urinary infection |
Infection of kidney, bladder, urethra, drainage around invasive device, or perinephric abscess |
Vascular infection |
Infection related to invasive vascular catheter |
Other infection |
Infection of any other known site |
Unknown infection |
Signs of infection present but unknown site (this category is not chosen if there is a clinically suspected site) |
Index organ dysfunction |
Organ dysfunction occurring within ± 3 days of a presumed infection |
Acute cardiovascular dysfunction |
Any one of the following persisting for ≥ 1 hour despite adequate fluid resuscitation: systolic blood pressure (SBP) < 90 mmHg unless known baseline SBP <90 mmHg ; SBP > 40 mmHg below baseline SBP; mean arterial pressure (MAP) < 70mmHg; vasopressor (if dopamine, > 5 mcg/kg/ min) requirement to maintain SBP > 90 or MAP > 70 mmHg |
Elevated serum lactate |
Serum lactate value above the normal range in combination with acute cardiovascular dysfunction on the same day |
Acute respiratory dysfunction |
PaO2 / FiO2 ratio ≤ 300 or PEEP requirement > 5 cm H20 in patients with acute lung injury (patients with cardiogenic pulmonary edema are excluded) |
Acute renal dysfunction |
Creatinine remains increased by > 1 mg/dL after adequate fluid resuscitation or creatinine ≥ 2 mg/dL in the absence of known baseline (patients on chronic dialysis excluded) |
Acute hematologic dysfunction |
Platelet (plt) count half of the highest value in last 3 days, or plt count <100,000mm3, or PT/PTT >1.5 times control in absence of anticoagulant |
Acute hepatic dysfunction |
Acute rise in serum total bilirubin to a level > 2 mg/dL |
Acute neurological dysfunction |
Acutely altered sensorium and all of the following: no known CNS injury, presence of sedation holiday, and Glasgow coma score (GCS) ≤ 12 |
fresh frozen plasma transfusion |
Any transfusion of fresh frozen plasma during the ICU stay |
Packed red blood cell (PRBC) transfusion |
Any transfusion of PRBCs during the first 21 days of ICU stay |
Intravenous nutrition |
Any administration of intravenous nutrition during the ICU stay |
Stress ulcer prophylaxis |
Any administration of stress ulcer prophylaxis during the ICU stay |
Hemodialysis catheter |
Placement of a hemodialysis catheter during the ICU stay |
Deep venous thrombosis (DVT) prophylaxis |
Administration of any of the following prophylactic treatments during the ICU stay: unfractionated, low-molecular weight, or synthetic heparin or spontaneous compression devices |
Invasive mechanical ventilation |
Administration of invasive mechanical ventilation upon ICU admission |
Chronic liver disease |
Any of the following: biopsy proven cirrhosis and documented portal hypertension; episodes of past upper GI bleeding attributed to portal hypertension; prior episodes of hepatic failure/ encephalopathy/ coma |
Chronic cardiovascular disease |
New York Heart Association Class IV symptoms and one or more of the following: severe coronary artery disease; severe valvular heart disease; severe cardiomyopathy |
Chronic respiratory disease |
Any of the following: chronic restrictive, obstructive or vascular disease resulting in severe mobility restriction; respiratory dependency; chronic hypoxia, hypercapnea, secondary polycythemia or severe pulmonary hypertension (>40 mmHg) |
Chronic renal disease |
A history of chronic renal compromise with most recent creatinine > 2.0 mg/dL |
Immunocompromise |
Any of the following: AIDS, immunosuppressive drugs, radiation or chemotherapy within 1 year of ICU admission, documented immuno-humoral or cellular immune deficiency state |
Active cancer within 5 years |
Any of the following in the past 5 years: solid organ tumor, hematological malignancy, lymphoma, or proven metastases |
Race |
African American / African European / Haitian) vs. “other.” The “other” category includes White / Caucasian, American Indian/ Alaska Native, Australian Aborigine, Asian/ Pacific Islander, Latin/ Hispanic, , other, or unknown. |
Payment source |
Medicaid insurance (including Medicaid managed care) or self-pay vs. other insurance. The other insurance category includes managed care, commercial/ indemnity insurance, Medicare, Medicare managed care, government insurance, national health service, or other. |
Critical care medicine (CCM) management |
A critical care medicine physician was responsible for the overall care of the patient for all or a portion of the patient’s ICU stay |
Hospital beds |
Number of licensed hospital beds |
Academic hospital |
Academic vs. “other” hospital. The “other” category includes city/ county, state, Veteran’s Administration, community/ for profit, and community/ not for profit. |
Medical school |
The hospital is the primary teaching hospital of an accredited medical school |
CCM fellowship program |
The hospital is the primary location of an accredited Critical Care Medicine fellowship |
Residency program |
The hospital is the primary location of an accredited residency program |